AI-generated summary
The authors report treating 120 patients with KOH-confirmed onychomycosis using a single session of a 1064-nm Nd:YAG q-switch laser. They report a 100% clinical response rate over a 9-month follow-up with no side effects. The abstract describes this as a novel and safe method, but its design details are limited.
- Participants
- 120
- Who or what was studied
- Patients with KOH-confirmed clinical diagnosis of onychomycosis
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract does not describe a control group, how response was defined or measured, or the number of patients followed to the end of the 9-month period.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.